Regeneron Pharmaceuticals Inc (REGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

August 2017 •
84 pages •
Report ID: 4962171 •
Format: PDF

Summary
Table of contents
Search Inside

Regeneron Pharmaceuticals Inc (REGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

Key Findings:
- Unique new report provides deep financial benchmarks for (Regeneron Pharmaceuticals Inc (REGN:NAS) compared to its top competitors and compared to the average for all companies within its primary industry.
- Benchmarking study for (Regeneron Pharmaceuticals Inc ) includes growth forecast for its primary industry to the year 2024.

The purpose of this report is to provide vital corporate-specific benchmarks, comparing the Subject Company to its top competitors (on a company-by-company basis) and to the averages within its primary industry for all key metrics.

This is a unique report containing high-value data. The report begins with a superb overview of the primary industry of the Subject Company, including historical industry revenues, revenue forecasts and CAGR. Then the report moves into industry averages and metrics, then into data specific to the Subject Company, with comparative data for the Subject Company’s top competitors.
This report will save countless hours of research and analytical work for the end user.

Core Benefits to Customer:
1) Comprehensive benchmarks for the Subject Company:
a. Benchmarked against the leading firms in its primary industry
b. Benchmarked against the average for publicly-held companies (U.S.) in its industry.
c. This includes financial results, ratios, vital statistics and metrics in one package, including historical and current metrics and averages for 6 years within its primary industry.
2) A snapshot overview of the company’s primary industry, including current and historic revenues and employment, along with a long term forecast for industry growth, with CAGR (compound annual growth rate), employee population and much more.
3) Detailed rankings of the Subject Company against top companies within the industry (U.S.-based firms) for key items including:
a. Approximate market capitalization
b. Employees
c. Revenues
d. Net income
e. 3-Year revenue growth (%)
f. 3-Year income growth (%)
g. Return on assets (%)
h. Return on equity (%)
i. Return on invested capital (%)
4) Leading companies-profiles of the Subject Company as well as profiles of top competitors within the industry

Pages: 84
Statistical Tables Provided: 28
Charts Provided: 14
Geographic: US

This report is part of the Plunkett’s Corporate Benchmarks series, published by the Plunkett Analytics unit of Plunkett Research, Ltd. Plunkett Research has unique capabilities for creating corporate and industry information, due to the industry and company research that we have been conducting for more than 20 years. Our access to hundreds of industry tables from our own databases, along with our databases of public and private company information, industry trends analysis and other resources, have been utilized in preparing this report. Similar reports are available for all significant, U.S. publicly-held firms.

Designed to benefit:
- Analysis and Financial Modeling
-Investment Professionals
- Lenders
- M&A Advisors
- Appraisers
- Consultants

Companies Profiled:
- Johnson & Johnson
- Procter & Gamble Co
- Pfizer Inc
- Dow Chemical Company (The)
- Merck & Co Inc
- Gilead Sciences Inc
- AbbVie Inc
- DuPont (E I du Pont de Nemours & Co)
- ExxonMobil Chemical
- Amgen Inc

Ahmad helps you find the right report:

+1 718 618 4302
Contact by email

FAQ

Testimonials

The market research advisor answered my questions quickly and professionally. ReportBuyer's team did their best to ensure that I felt comfortable before making the investment to purchase the report.

Cristian Nunez

Director of Corporate Development Chugach Alaska Corporation

My overall experience with ReportBuyer today has been very positive, and I must thank you for your patience (...). Also, the sample you sent me and the explanations provided were very helpful.

D. Lescuyer

Executive Vice President Oral Business at Skyepharma

The research specialist was very helpful, and proposed the best content for my needs. ReportBuyer also offered a great follow-up, thanks for everything !

P. Thompson

EMEA Managing Director

We were satisfied with the support that ReportBuyer's team provided. Thanks to their recommendations, the report we purchased provided exactly what we want.

Y. Wang

Business Analyst

We didn't have time to do the research internally, and thanks to ReportBuyer's team we were able to find the appropriate data.

S. Chen

Research Coordinator

I was impressed by the customer service: it was fast, responsive, and 100% professional !

D. Krivan

Market Research Analyst

The research specialist provided prompt and helpful service. He also followed up to ensure I had all the information to deliver my business development plan.

C. Adams

Senior Business Development Manager